Latest Breaking News On - பிளாட்டிரான் ஆரோக்கியம் - Page 18 : comparemela.com
New Education Fund to Invest in Women in Cybersecurity Careers
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Sistema de información oncológica mercado: hechos, cifras y perspectivas analíticas 2021-2030 por jugadores de marca: Accuray Incorporated, Altos Solutions | Marketresearch biz
revistacrossover.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from revistacrossover.com Daily Mail and Mail on Sunday newspapers.
MedCity News
Will IBM’s reported desire to sell Watson cast a shadow over big tech’s healthcare ambitions?
IBM is reportedly looking to sell its Watson Health business. If true, it would be another stumble in a much-hyped healthcare project by a technology company.
Shares1
When IBM first launched its Watson Health unit in 2015, it had to live up to a grandiose vision. The company’s AI creation, popularized by its win on Jeopardy!, was pitched to oncologists as a tool that could comb through medical literature and cancer patients’ health records, detecting patterns that they could not.
Reports later found that it fell short of those claims, and in some cases, offered ‘unsafe and incorrect’ suggestions. Now, IBM might be considering selling its Watson Health unit, as it focuses more on its cloud computing business, according to the Wall Street Journal. Citing anonymous sources, the Journal reported the health unit brought in $1 billion in revenue and isn’t currentl
Posted on 179
H3 Biomedicine Inc. (H3), a U.S.-based precision medicine research & development subsidiary of Eisai Co., Ltd., today announced a partnership with Flatiron Health, a healthcare technology and services company focused on accelerating cancer research and improving patient care, and Foundation Medicine, a genomic insights company, to expand its use of real-world data in the research and development of drugs for the potential treatment of cancer.
H3 will use Flatiron Health and Foundation Medicine’s extensive, real-world clinico-genomic database (CGDB) to accelerate its research and development efforts as well as aid in the design of clinical trials. The CGDB links comprehensive genomic profiling (CGP) data from patients who underwent CGP testing by a Foundation Medicine assay with clinical outcomes data for patients in the Flatiron Health network.
Singapore announces precision oncology partnership
Singapore announces precision oncology partnership 10 February 2021 | News Public sector partners will provide research expertise and insights to build infrastructure for data sharing, and Roche will provide access to genomic testing and guidance on infrastructure design and implementation
Photo Credit: Roche Singapore
Singapore Translational Cancer Consortium (STCC), National Cancer Centre Singapore (NCCS), the National University Cancer Institute, Singapore (NCIS) at the National University Hospital (NUH) and Roche announced a unique and groundbreaking partnership between public and private sector institutions in Singapore aimed at establishing a critical infrastructure to advance the adoption of personalised healthcare in Singapore. Personalised healthcare, which includes precision oncology or personalised cancer care, leverages insights from medical and genomic data to help make more precise treatment decisions
vimarsana © 2020. All Rights Reserved.